New smart drug targets, reduces site-specific inflammation
Wednesday, July 22, 2015 - 14:00
in Health & Medicine
The uniqueness of a new novel anti-inflammatory molecule can be found in a singular property. When injected, it is as a non-active drug. However, a localized site with excessive inflammation will activate it. Most other anti-inflammatory agents effectively inhibit inflammatory processes, though in a non-specific manner and in areas that include sites of necessary normal inflammatory homeostasis.